MIMS news

MIMS travel advice partner NaTHNaC celebrates 15-year anniversary

MIMS travel advice partner NaTHNaC celebrates 15-year anniversary

The National Travel Health Network and Centre (NaTHNaC),...

Enjoy the benefits of MIMS Learning membership

Enjoy the benefits of MIMS Learning membership

Become a member of MIMS Learning for just £2.49+VAT...

Arthritis biologic approved for NHS prescribing

Arthritis biologic approved for NHS prescribing

Sarilumab (Kevzara) is to be funded on the NHS, following...

Fingerprick-free glucose monitoring system available on the NHS

Fingerprick-free glucose monitoring system available on the NHS

A glucose monitoring system that does not require regular...

Risk of serious skin reactions with anaemia drugs

Risk of serious skin reactions with anaemia drugs

Severe cutaneous adverse reactions can occur in patients...

Clozapine prescribers reminded of intestinal obstruction risk

Clozapine prescribers reminded of intestinal obstruction risk

Clozapine can impair intestinal peristalsis, leading...

Adjust gabapentin dose to avoid respiratory depression, MHRA advises

Adjust gabapentin dose to avoid respiratory depression, MHRA advises

Prescribers may need to adjust the dose of gabapentin...

Cows' milk allergy warning over methylprednisolone use

Cows' milk allergy warning over methylprednisolone use

Lactose-containing methylprednisolone preparations...

Advise women to take combined contraceptive pills continuously, says family planning expert

Advise women to take combined contraceptive pills continuously, says family planning expert

The 21/7 contraceptive pill regimen is 'outdated' and...

Malaria prevention guidelines updated

Malaria prevention guidelines updated

Public Health England (PHE) has updated its guidance...

Combined LABA/steroid inhaler added to Easyhaler range

Combined LABA/steroid inhaler added to Easyhaler range

Fobumix Easyhaler 320/9 (budesonide/formoterol) is...

Tofacitinib approved by NICE for severe rheumatoid arthritis

Tofacitinib approved by NICE for severe rheumatoid arthritis

The JAK inhibitor tofacitinib (Xeljanz) has been endorsed...

New salmeterol/fluticasone MDI extends choice in asthma prescribing

New salmeterol/fluticasone MDI extends choice in asthma prescribing

Aloflute (salmeterol/fluticasone) metered dose inhaler...

NICE approves reslizumab for severe eosinophilic asthma

NICE approves reslizumab for severe eosinophilic asthma

NICE has approved the use of reslizumab (Cinqaero)...

Hepatitis B vaccination added to routine schedule

Hepatitis B vaccination added to routine schedule

The hexavalent DTaP/IPV/HiB/HBV vaccine Infanrix hexa...

Warfarin interaction warning for miconazole oral gel

Warfarin interaction warning for miconazole oral gel

Miconazole oral gel should be prescribed with caution...

High loperamide doses linked to serious cardiac reactions

High loperamide doses linked to serious cardiac reactions

Cardiac events including QT prolongation, torsades...

Two new glaucoma preparations in preservative-free multi-dose bottles

Two new glaucoma preparations in preservative-free multi-dose bottles

Eydelto (dorzolamide) and Eylamdo (dorzolamide/timolol)...

First oral short-course treatment for MS

First oral short-course treatment for MS

Mavenclad (cladribine) is licensed for the treatment...

Epilepsy treatment now available as licensed medicine

Epilepsy treatment now available as licensed medicine

Epistatus (midazolam), previously classified as an...

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases